Patients with Allan‐Herndon‐Dudley Syndrome ( MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment
Movement Disorders · 2025-05 · 40 (5) · 938-949
DOI: 10.1002/mds.30152 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Movement Disorders, online erschienen am 15.03.2025. Verfasst von Nina-Maria Wilpert und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropediatrics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and …. Hauptthemen laut MEDLINE: Levodopa, Carbidopa, X-Linked Intellectual Disability, Parkinsonian Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alliance4Rare, Bundesministerium für Bildung und ForschungGerman Center for Child and Adolescent Health (DZK), Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Patients with mutations in the monocarboxylate transporter 8 (MCT8, SLC16A2 ) suffer from X‐linked recessive Allan‐Herndon‐Dudley syndrome (AHDS), which is characterized by developmental delay and a severe movement disorder. Current trials using thyroid hormone derivatives to overcome the transporter defect have failed to achieve patient‐oriented therapeutic goals.
Objectives
Our aim was to define the type of movement disorder in AHDS in an observational cohort study and to investigate the causative role of the dopaminergic system.
Methods
We present longitudinal clinical data from the DEEPTYPE registry of 11 patients with video documentation, standardized phenotyping, cerebrospinal fluid (CSF) analysis, neuroimaging data, and the treatment response to levodopa/carbidopa supplementation.
Results
Children presented with signs of childhood parkinsonism, including hypokinesia, hypomimia, inability to sit or stand, rigidity, dystonia, and autonomic dysfunction. CSF homovanillic acid concentrations were decreased (n = 12), suggesting an isolated dopamine pathway impairment. Seven out of 8 patients responded favorably to l ‐dopa/carbidopa supplementation and we did not observe any adverse drug reactions.
Conclusions
AHDS is associated with childhood parkinsonism, which is linked with biochemical abnormalities of dopamine metabolism. It can be treated with l ‐dopa/carbidopa supplementation. However, further research is needed to elucidate the exact effect of MCT8 deficiency on dopamine metabolism. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropediatrics, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
- Center for Chronically Sick Children, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
- NeuroCure Cluster of Excellence, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), Berlin, Germany.
- BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Berlin, Germany.
- Division of Movement Disorders, Department of Neurology, University of Rochester Medical Center, Motor Physiology and Neuromodulation Program, Rochester, New York, USA.
- Division of Child Neurology, Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA.
ORCID-Profile: Nina-Maria Wilpert, Angela L Hewitt, Roser Pons, Marie-Thérèse Henke, Andrea Dell'Orco, Martin Bauer, Annika Zink, Alessandro Prigione, Christina Reinauer, Catharina Lange, Christian Furth, Sabine Jung-Klawitter, Angela M Kaindl, Anna Tietze, Heiko Krude, Thomas Opladen, Markus Schuelke
Förderung
- Alliance4Rare
- Bundesministerium für Bildung und ForschungGerman Center for Child and Adolescent Health (DZK)
- Deutsche Forschungsgemeinschaft
- Berliner Sparkassenstiftung Medizin
- Berlin Institute of Health
- BIH Charité Junior Clinician Scientist Program for Rare
Zitieren
APA
Wilpert, N. M., Hewitt, A. L., Pons, R., Henke, M. T., Dell'Orco, A., Bauer, M., Grolik, C., Menz, S., Wahle, M., Zink, A., Prigione, A., Reinauer, C., Lange, C., Furth, C., Brockmann, K., Jung-Klawitter, S., Christ, S., Kaindl, A. M., Tietze, A., …, & Schuelke, M. (2025). Patients with Allan‐Herndon‐Dudley Syndrome ( MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment. Movement Disorders, 40(5), 938-949. https://doi.org/10.1002/mds.30152
Vancouver
Wilpert NM, Hewitt AL, Pons R, Henke MT, Dell'Orco A, Bauer M, et al. Patients with Allan‐Herndon‐Dudley Syndrome ( MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment. Movement Disorders. 2025;40(5):938-949. doi:10.1002/mds.30152
BibTeX
@article{Wilpert2025,
author = {Wilpert, Nina-Maria and Hewitt, Angela L and Pons, Roser and Henke, Marie-Thérèse and Dell'Orco, Andrea and Bauer, Martin and Grolik, Christiane and Menz, Stephan and Wahle, Monika and Zink, Annika and Prigione, Alessandro and Reinauer, Christina and Lange, Catharina and Furth, Christian and Brockmann, Knut and Jung-Klawitter, Sabine and Christ, Stine and Kaindl, Angela M and Tietze, Anna and Krude, Heiko and Opladen, Thomas and Schuelke, Markus},
title = {Patients with Allan‐Herndon‐Dudley Syndrome ( MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {5},
pages = {938--949},
doi = {10.1002/mds.30152}
}
EUVIMED